AIMS/HYPOTHESIS: The rs1990760 polymorphism (Ala946Thr) of interferon induced with helicase C domain 1 (IFIH1) has been proposed to associate with type 1 diabetes. In this study, association between IFIH1 Ala946Thr and type 1 diabetes was investigated in two distinct white populations, the Hungarians and Finns. METHODS: The rs1990760 polymorphism was genotyped in 757/509 Hungarian/Finnish childhood-onset cases, 499/250 Hungarian/Finnish control individuals and in 529/924 Hungarian/Finnish nuclear family trios. Disease association was tested using case-control and family-based approaches. A meta-analysis of data from 9,546 cases and 11,000 controls was also performed. RESULTS: In the Hungarian dataset, the A allele was significantly more frequent among cases than among controls (OR 1.29, 95% CI 1.10-1.52; p = 0.002). Combined analysis of Hungarian and Finnish datasets revealed a strong disease association (OR 1.235, 95% CI 1.083-1.408; p = 0.002). Furthermore, the A allele was significantly overtransmitted in both family trio datasets (p = 0.017 in Hungarians; p = 0.007 in Finns). The A allele was increased in Hungarian vs Finnish cases (64.9% vs 60.8% in Finns; p = 0.003). The meta-analysis yielded a significant effect for IFIH1 rs1990760 A allele on type 1 diabetes risk (OR 1.176, 95% CI 1.130-1.225; p = 5.3 x 10(-15)) with significant heterogeneity between effect sizes across the studied populations (p = 0.023). CONCLUSIONS/ INTERPRETATION: This study represents the first independent confirmation of the association between type 1 diabetes and the IFIH1 gene in Hungarian and Finnish populations. Summarising the data published so far, a clear association between the Ala946Thr polymorphism and type 1 diabetes was detected, with an apparent difference in the contribution to disease susceptibility in different populations of European ancestry.
AIMS/HYPOTHESIS: The rs1990760 polymorphism (Ala946Thr) of interferon induced with helicase C domain 1 (IFIH1) has been proposed to associate with type 1 diabetes. In this study, association between IFIH1 Ala946Thr and type 1 diabetes was investigated in two distinct white populations, the Hungarians and Finns. METHODS: The rs1990760 polymorphism was genotyped in 757/509 Hungarian/Finnish childhood-onset cases, 499/250 Hungarian/Finnish control individuals and in 529/924 Hungarian/Finnish nuclear family trios. Disease association was tested using case-control and family-based approaches. A meta-analysis of data from 9,546 cases and 11,000 controls was also performed. RESULTS: In the Hungarian dataset, the A allele was significantly more frequent among cases than among controls (OR 1.29, 95% CI 1.10-1.52; p = 0.002). Combined analysis of Hungarian and Finnish datasets revealed a strong disease association (OR 1.235, 95% CI 1.083-1.408; p = 0.002). Furthermore, the A allele was significantly overtransmitted in both family trio datasets (p = 0.017 in Hungarians; p = 0.007 in Finns). The A allele was increased in Hungarian vs Finnish cases (64.9% vs 60.8% in Finns; p = 0.003). The meta-analysis yielded a significant effect for IFIH1rs1990760 A allele on type 1 diabetes risk (OR 1.176, 95% CI 1.130-1.225; p = 5.3 x 10(-15)) with significant heterogeneity between effect sizes across the studied populations (p = 0.023). CONCLUSIONS/ INTERPRETATION: This study represents the first independent confirmation of the association between type 1 diabetes and the IFIH1 gene in Hungarian and Finnish populations. Summarising the data published so far, a clear association between the Ala946Thr polymorphism and type 1 diabetes was detected, with an apparent difference in the contribution to disease susceptibility in different populations of European ancestry.
Authors: R Hermann; C S Bartsocas; Gy Soltész; A Vazeou; P Paschou; E Bozas; A Malamitsi-Puchner; O Simell; M Knip; J Ilonen Journal: Diabetes Metab Res Rev Date: 2004 Jul-Aug Impact factor: 4.876
Authors: Siyang Liu; Hongjie Wang; Yulan Jin; Robert Podolsky; M V Prasad Linga Reddy; Jennifer Pedersen; Bruce Bode; John Reed; Dennis Steed; Steve Anderson; Ping Yang; Andy Muir; Leigh Steed; Diane Hopkins; Yihua Huang; Sharad Purohit; Cong-Yi Wang; Andrea K Steck; Annalisa Montemari; George Eisenbarth; Marian Rewers; Jin-Xiong She Journal: Hum Mol Genet Date: 2008-10-16 Impact factor: 6.150
Authors: Folefac Aminkeng; Jan E Van Autreve; Ilse Weets; Erik Quartier; Chris Van Schravendijk; Frans K Gorus; Bart J Van der Auwera Journal: Hum Immunol Date: 2009-06-16 Impact factor: 2.850
Authors: Mikael Knip; Riitta Veijola; Suvi M Virtanen; Heikki Hyöty; Outi Vaarala; Hans K Akerblom Journal: Diabetes Date: 2005-12 Impact factor: 9.461
Authors: Deborah J Smyth; Jason D Cooper; Rebecca Bailey; Sarah Field; Oliver Burren; Luc J Smink; Cristian Guja; Constantin Ionescu-Tirgoviste; Barry Widmer; David B Dunger; David A Savage; Neil M Walker; David G Clayton; John A Todd Journal: Nat Genet Date: 2006-05-14 Impact factor: 38.330
Authors: Hanna Viskari; Johnny Ludvigsson; Raivo Uibo; Lina Salur; Dalia Marciulionyte; Robert Hermann; Gyula Soltesz; Martin Füchtenbusch; Anette-G Ziegler; Anita Kondrashova; Anatolij Romanov; Mikael Knip; Heikki Hyöty Journal: J Med Virol Date: 2004-04 Impact factor: 2.327
Authors: Benjamin M Looney; Chang-Qing Xia; Patrick Concannon; David A Ostrov; Michael J Clare-Salzler Journal: Curr Diab Rep Date: 2015-11 Impact factor: 4.810
Authors: Ondrej Cinek; German Tapia; Elisabet Witsø; Lenka Kramna; Katerina Holkova; Trond Rasmussen; Lars C Stene; Kjersti S Rønningen Journal: PLoS One Date: 2012-11-07 Impact factor: 3.240
Authors: Margrit Urbanek; M Geoffrey Hayes; Hoon Lee; Rachel M Freathy; Lynn P Lowe; Christine Ackerman; Nadereh Jafari; Alan R Dyer; Nancy J Cox; David B Dunger; Andrew T Hattersley; Boyd E Metzger; William L Lowe Journal: PLoS One Date: 2012-03-30 Impact factor: 3.240
Authors: Ana P Bouças; Letícia A Brondani; Bianca M Souza; Natália E Lemos; Fernanda S de Oliveira; Luis H Canani; Daisy Crispim Journal: PLoS One Date: 2013-12-27 Impact factor: 3.240